Keeping Covid-19 patients off ventilators

Israel’s Respinova developed Pulsehaler to help COPD patients improve their lungs and avoid ventilation. Repinova is now preparing for clinical trials in Israel on patients suffering from acute respiratory distress syndrome (ARDS) as caused by Covid-19.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.